JCX-8-23 (May 09, 2023)

Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy

The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.”  The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.

 

Related Publications

  • JCX-26-24 (May 23, 2024)

    Overview Of The Federal Tax System As In Effect For 2024

    view details
  • JCX-13-24 (April 16, 2024)

    Description Of The Chairman's Amendment In The Nature Of A Substitute to H.R. 7980, The "End Chinese Dominance Of Electric Vehicles In America Act of 2024"

    view details
  • JCX-12-24 (April 16, 2024)

    Description Of The Chairman's Amendment In The Nature Of A Substitute to H.R. 7983, The "Stop Executive Overreach On Trade Agreements Act"

    view details